SEC Form D private-offering filing

ARTELO BIOSCIENCES, INC.

A new SEC Form D private-offering notice from Solana Beach, CA, a $3,718,121 filer-stated offering target in Biotech. The source filing is one click away.

ARTELO BIOSCIENCES, INC. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing lipid signaling therapeutics for cancer, anorexia, anxiety, pain and inflammation, publicly traded on Nasdaq as ARTL

Filed 2025-11-10Filed to raise $3,718,121First money in 2025-10-28Raised so far $3,718,121HQ (as filed) Solana Beach, CASector Biotech Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified artelobio.com↗Named in the filing 8 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.